• Research Use Only (RUO)
  • Free shipping on orders over $200
  • Free shipping on orders over $200
  • Free shipping on orders over $200
  • Research Use Only (RUO)
  • Free shipping on orders over $200
  • Free shipping on orders over $200
  • Free shipping on orders over $200

RESEARCH USE ONLY

This product is for R&D purposes only and is not approved for human or veterinary use.

Ipamorelin/CJC-1295 (w/o DAC) 5/5MG

Categories:

Ipamorelin / CJC-1295 (without DAC) is a research peptide blend supplied for controlled laboratory studies. Researchers use this combination in structured research focused on peptide signaling and interaction behavior.

  • Combination of Ipamorelin and CJC-1295 without a Drug Affinity Complex
  • Used in laboratory research focused on peptide signaling and interaction models
  • Suitable for controlled and repeatable research workflows

$60.00

9 in stock

9 in stock

RESEARCH USE ONLY

This product is for R&D purposes only and is not approved for human or veterinary use.

Guaranteed Safe Checkout

Current Research

Ipamorelin, the First Selective Growth Hormone Secretagogue 

Prolonged Stimulation of Growth Hormone (GH) and Insulin-like Growth Factor I Secretion by CJC-1295 

Support Based in the U.S.

Our customer service representatives are here to answer your questions Monday through Friday 9am - 6pm EST

Certified Quality

Certificate of analysis available for all products

Quantity Discounts

Earn up to 15% off when you purchase more products per shipment

Ipamorelin / CJC-1295 (Without DAC) Research Peptide Blend

Ipamorelin / CJC-1295 (without DAC) is a research peptide blend supplied for controlled laboratory investigation. Researchers study this combination in structured research focused on peptide signaling, receptor interaction models, and sequence specific behavior within experimental systems. The absence of a Drug Affinity Complex allows laboratories to examine peptide activity without extended binding modifications.

Because this blend combines two distinct peptides, researchers use it to explore how paired peptide signaling behaves under controlled research conditions. The non-DAC form of CJC-1295 allows scientists to study shorter acting peptide dynamics and interaction patterns within experimental models. As a result, laboratories can generate clear and repeatable data while maintaining precise control over experimental variables.

In laboratory settings, scientists handle Ipamorelin / CJC-1295 (without DAC) using standard peptide preparation and safety procedures. The peptide format supports accurate measurement and controlled application during experiments. Therefore, research teams can maintain stable testing conditions and focus on observation, documentation, and data analysis.

Researchers value this peptide blend for its defined structure and compatibility with structured research workflows. Its consistent composition helps reduce variation during experimentation and supports comparison across studies involving single and combined peptide sequences. In addition, the non-DAC formulation makes it suitable for research projects that focus on peptide behavior without extended binding effects.

Ongoing scientific research continues to include Ipamorelin / CJC-1295 (without DAC) in peptide focused laboratory studies. Its defined composition, predictable handling characteristics, and suitability for controlled research models make it a useful tool for advanced experimental work.

Important Notice

Ipamorelin / CJC-1295 (without DAC) is provided strictly for research use only. This product is not intended for human or animal use, clinical applications, diagnostic procedures, or consumption of any kind. All research must be conducted by qualified professionals in appropriate laboratory environments and in compliance with applicable regulations and guidelines.

Reviews

There are no reviews yet.

Be the first to review “Ipamorelin/CJC-1295 (w/o DAC) 5/5MG”

Your email address will not be published. Required fields are marked *

Age Verification!

*By continuing, you confirm eligibility and legal compliance.